Clinical Studies Summary
  International Distributor
Call us Toll Free in North America
US / Canada: 1-888-604-4561

Email: helpdesk@exorex.com


Check out our new linotar.com website:

Clinical Studies Summary

Exorex (=Linotar) superior to conventional coal tar lotion


Exorex (Linotar) is superior to a conventional coal tar lotion (5%) for treatment of mild to moderate psoriasis, and may be preferred as a first-line topical treatment according to a study published in the 2003 issue of the Journal of Dermatological Treatment.



These are the key results of this clinical study:



1. Exorex (Linotar) is superior to a conventional coal tar lotion in treating psoriasis.

2. Exorex (Linotar) may be the preferred option for first-line topical treatment.

3. Doctors’ and patients’ assessments showed a preference for using Exorex.

4. Exorex (Linotar) is well tolerated and produced fewer skin reactions.

5. Exorex (Linotar) was cosmetically acceptable to patients.



Conclusion:



Based on these results the study concluded that Exorex (Linotar) is significantly more effective than a conventional coal tar lotion in mild to moderate psoriasis and may be preferred for first-line topical treatment.



Reference: Journal of Dermatological Treatment (2003) 14, 1-9.





Exorex as effective as Dovonex (Daivonex)


Exorex has been found to be as effective as Dovonex (Daivonex) in treating psoriasis in a study published in the August 2003 issue of the British Journal of Dermatology.



These are the key results of this clinical study:



1. Exorex is as effective as Dovonex in treating psoriasis.

2. Exorex provided the same length of psoriasis remission as Dovonex.

3. The cosmetic properties of Exorex were greatly improved over other coal tar products.

4. Exorex is several times less expensive than Dovonex (Daivonex).



Conclusion:



Based on these results the study concluded that Exorex is a very useful topical treatment for chronic moderate-to-severe plaque type psoriasis.



Reference: British Journal of Dermatology 2003; 149: 350-353